

Prof Nico Wulffraat
Professor Nico Wulffraat is a paediatric rheumatologist and immunologist and full professor within the Department of Paediatrics, Subunit Paediatric Immunology and Rheumatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, The Netherlands.
Professor Wulffraat completed his medical degree at the Free University, Amsterdam, The Netherlands, and was later awarded a PhD from the same institution. His research interests focus on paediatric rheumatology, and he set up the European project Pharmachild and the European project SHARE on clinical guidelines in paediatric rheumatology. Additionally, Professor Wulffraat is the coordinator of the European Reference Network (ERN) RITA.
Professor Wulffraat is a member of committees such as the Gezondheidsraad Advies CVS (chronic fatigue syndrome) and the Evaluatie Beoordeling NFU Expertisecentra. He has also contributed to over 330 peer-reviewed papers.
Explore which treatment targets may be more appropriate for making treatment decisions in axSpA.
PsA and axSpA have overlapping disease manifestations which are driven by inflammation.1 Explore several extracellular cytokines that are implicated in these...
Watch Prof Frank Behrens discuss the importance of treating skin symptoms in addition to musculoskeletal symptoms for patients with SpA.
Achieving ACR50 is associated with improvements in quality of life for patients with PsA.1 Dive into the data supporting higher treatment targets in clinical...
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...